ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES

Exclusion Criteria

• •Subject is participating in a concurrent study which may confound study results
• •Subject has a life expectancy \<2 year
• •Subject is female of childbearing potential in whom pregnancy cannot be excluded
• •Subject with eGFR \<30 mL/min/m2 (KDOQI classification - exclude class IV and above) and or on dialysis
• •Subject with a MI or CVA within 3 months prior to index procedure
• •Subject with known Connective Tissue Disease
• •Subject has a known hypersensitivity or contraindication to anticoagulants, antiplatelets, or contrast media, which is not amenable to post-treatment
• •Subject who has undergone prior endovascular or open surgical treatment for abdominal aortic aneurysm
• •Subject requires emergent aneurysm treatment, for example, trauma or rupture
• •Subject has a known hypersensitivity or allergies to study device implant material
• •Subject has an aneurysm that is:
• •* Suprarenal, pararenal, or thoracoabdominal
• •* Mycotic
• •* Inflammatory
• •* Pseudoaneurysm
• •Subject is presenting with thrombus or calcification of the proximal aneurysm neck: circumferential \>50%
• •Pre-op stenosis of the renal arteries \> 50%
• •Subject has active infection or history of COVID-19. History of COVID-19 is defined as availability of positive COVID-19 test with sequelae or hospitalization for treatment of COVID-19.